Results 151 to 160 of about 110,178 (262)

Content validity assessment and modification of the FACE-Q craniofacial module for retinoblastoma survivors. [PDF]

open access: yesPLoS One
Khan F   +9 more
europepmc   +1 more source

Clinical Significance of Biomarkers in Oropharyngeal Squamous Cell Carcinoma: Recurrence Prediction and Treatment Response

open access: yesCancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Oropharyngeal squamous cell carcinoma (OPSCC) accounts for a substantial proportion of head and neck cancers, with a rising incidence largely driven by human papillomavirus (HPV) infection. Despite advances in multimodal treatment, disease recurrence remains common and limits long‐term survival, highlighting the need for reliable ...
Yunxia Chen   +7 more
wiley   +1 more source

Incidence of Second Malignancies Among Children Treated for Cancer With Radiotherapy in Egypt

open access: yesCancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Survivors of childhood cancer (CCS) are at risk for secondary malignant neoplasms (SMNs): serious late effects of treatment. Radiotherapy (RT) and chemotherapy (CT) are possible causes of SMNs. Aims To measure SMN incidence and characteristics among Egyptian CCS treated with RT, and to compare SMN timing and location based on RT ...
Charlotte L. Sackett   +6 more
wiley   +1 more source

Management of Retinoblastoma: A Challenge in Pediatric Ophthalmology. [PDF]

open access: yesLife (Basel)
Cruz-Gálvez CC   +6 more
europepmc   +1 more source

Resveratrol for Cancer Radio‐Sensitization: Ready for Prime Time or Future Perspective

open access: yesFood Science &Nutrition, Volume 14, Issue 5, May 2026.
Resveratrol exerts antioxidant and anti‐inflammatory effects by reducing reactive oxygen species and suppressing NF‐κB and JAK/STAT signaling pathways. It modulates metabolic signaling through AMPK‐dependent inhibition of mTOR, influencing cell survival and inflammatory responses.
Maryam Fallah   +7 more
wiley   +1 more source

Exploring the Relationship Between MDM4 Gene Polymorphisms (rs1380576 and rs4245739) and Breast Cancer Susceptibility in Bangladesh: A Case–Control Study

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 9, May 2026.
Our findings indicated that the rs4245739 A>C polymorphism was not associated with BC risk in the Bangladeshi population, whereas the rs1380576 C>G polymorphism was significantly associated with BC risk. This study provides new insights into the genetic factors influencing breast cancer susceptibility in the Bangladeshi population, highlighting the ...
J. M. Aousiful Islam   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy